The U.S. Justice Department announces pharmaceutical companies Genentech Inc. and OSI Pharmaceuticals Inc. will pay $67 million to settle False Claims Act allegations for misleading statements about the effectiveness of the drug Tarceva in treating non-small-cell lung carcinoma. (UPI)